CNQ · MJRX.CN
Global Health Clinics Ltd.
CA$0.40CA$0.00 (0.0%)
Global Health Clinics Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
Loading market information…
TSXV · VXL.V · CAD
Stock price, earnings
Quote as of Oct 28, 2026, 07:23 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Vaxil Bio Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vaxil Bio Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.40CA$0.00 (0.0%)
Global Health Clinics Ltd.’s quoted price sits in the upper half of its reported 52-week range, 9.09% below the high.
CA$0.10CA$0.00 (0.0%)
Entheon Biomedical Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.09-CA$0.02 (-15.0%)
Doseology Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.5% below the high.
CA$0.63CA$0.00 (0.0%)
Vibe Growth Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.25% below the high.
CA$0.01-CA$0.01 (-50.0%)
Optimind Pharma Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.01CA$0.00 (0.0%)
Greenrise Global Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.02$0.00 (0.0%)
TripSitter Clinic Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.27% below the high.
$0.01$0.00 (0.0%)
CENTR Brands Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.38% below the high.
